121 related articles for article (PubMed ID: 27443665)
1. Comparative effectiveness of histamine-2 receptor antagonists as short-term therapy for gastro-esophageal reflux disease: a network meta-analysis.
Zhao F; Wang S; Liu L; Wang Y
Int J Clin Pharmacol Ther; 2016 Oct; 54(10):761-70. PubMed ID: 27443665
[TBL] [Abstract][Full Text] [Related]
2. Short-term treatment of gastroesophageal reflux disease.
van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Yoshino T; Shio S; Hayakumo T; Kawai K
Nihon Rinsho; 2004 Aug; 62(8):1504-9. PubMed ID: 15344541
[TBL] [Abstract][Full Text] [Related]
6. [Maintenance therapy of mild form of GERD by H2 receptor antagonists].
Kurosawa S
Nihon Rinsho; 2000 Sep; 58(9):1859-64. PubMed ID: 11004816
[TBL] [Abstract][Full Text] [Related]
7. Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
[TBL] [Abstract][Full Text] [Related]
8. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.
Tougas G; Armstrong D
Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux and histamine2 antagonists.
Bell SG
Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
[No Abstract] [Full Text] [Related]
11. Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease.
Engzelius JM; Solhaug JH; Knapstad LJ; Kjaersgaard P
Scand J Gastroenterol; 1997 Jun; 32(6):513-8. PubMed ID: 9200279
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H
Zhang C; Kwong JS; Yuan RX; Chen H; Xu C; Wang YP; Yang GL; Yan JZ; Peng L; Zeng XT; Weng H; Luo J; Niu YM
Sci Rep; 2017 Jan; 7():41021. PubMed ID: 28102361
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of histamine-2 receptor antagonists.
van der Pol R; Langendam M; Benninga M; van Wijk M; Tabbers M
JAMA Pediatr; 2014 Oct; 168(10):947-54. PubMed ID: 25133940
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
16. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
17. On-demand therapy in gastroesophageal reflux disease: a comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets.
Johannessen T; Kristensen P
Clin Ther; 1997; 19(1):73-81. PubMed ID: 9083710
[TBL] [Abstract][Full Text] [Related]
18. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy.
Rackoff A; Agrawal A; Hila A; Mainie I; Tutuian R; Castell DO
Dis Esophagus; 2005; 18(6):370-3. PubMed ID: 16336606
[TBL] [Abstract][Full Text] [Related]
19. [Gastroesophageal reflux disease in preschool children with asthma].
Yoshida Y; Kameda M; Nishikido T; Takamatu I; Doi S
Arerugi; 2008 May; 57(5):529-35. PubMed ID: 18520174
[TBL] [Abstract][Full Text] [Related]
20. The clinical use of histamine-2 receptor antagonists.
Michocki RJ; Richardson JP
Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]